| Dr Xi Z Damrell, MD | |
|
400 W Mineral King Ave, Visalia, CA 93291 | |
| (559) 624-5218 | |
| Not Available |
| Full Name | Dr Xi Z Damrell |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 400 W Mineral King Ave, Visalia, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154490647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A146396 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy General Hospital | Sacramento, CA | Hospital |
| Mercy San Juan Medical Center | Carmichael, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Today, Lung Cancer Alliance (LCA) announced that the Department of Veterans Affairs (VA) has agreed to move forward on CT screening for veterans at high risk for lung cancer. This was communicated to Laurie Fenton Ambrose, LCA President & CEO in written correspondence by VA Under Secretary for Health Dr. Robert A. Petzel.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American patients is being presented today at the Society for Cardiovascular Angiography and Interventions 2021 Virtual Scientific Sessions.
People who have modestly but measurably worse lung function are more likely to suffer sudden cardiac death (SCD), according to research presented at the European Respiratory Society International Congress.
› Verified 3 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Today, Lung Cancer Alliance (LCA) announced that the Department of Veterans Affairs (VA) has agreed to move forward on CT screening for veterans at high risk for lung cancer. This was communicated to Laurie Fenton Ambrose, LCA President & CEO in written correspondence by VA Under Secretary for Health Dr. Robert A. Petzel.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American patients is being presented today at the Society for Cardiovascular Angiography and Interventions 2021 Virtual Scientific Sessions.
People who have modestly but measurably worse lung function are more likely to suffer sudden cardiac death (SCD), according to research presented at the European Respiratory Society International Congress.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Xi Z Damrell, MD 400 W Mineral King Ave, Visalia, CA 93291-6237 Ph: (559) 624-5218 | Dr Xi Z Damrell, MD 400 W Mineral King Ave, Visalia, CA 93291 Ph: (559) 624-5218 |
News Archive
Today, Lung Cancer Alliance (LCA) announced that the Department of Veterans Affairs (VA) has agreed to move forward on CT screening for veterans at high risk for lung cancer. This was communicated to Laurie Fenton Ambrose, LCA President & CEO in written correspondence by VA Under Secretary for Health Dr. Robert A. Petzel.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American patients is being presented today at the Society for Cardiovascular Angiography and Interventions 2021 Virtual Scientific Sessions.
People who have modestly but measurably worse lung function are more likely to suffer sudden cardiac death (SCD), according to research presented at the European Respiratory Society International Congress.
› Verified 3 days ago
John W. T. Walker, M.D Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1633 S Court St, Visalia, CA 93277 Phone: 559-635-6090 | |
Dr. Sean Hampton Oldroyd, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-5218 | |
Lori Danielle Winston, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 520 W Mineral King Ave, Kaweah Delta Health Care District - Ssb 5th Floor, Visalia, CA 93291 Phone: 559-624-5215 | |
Steve Rosonke, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2213 Fax: 559-635-4024 | |
Steven John Carstens, D.O Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2215 | |
Dr. Michael John Kastner, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2000 | |
Eric Michael Patten, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2000 |